ReleaseWire Connect

This report covers the global dermatology market. The key dermatological indications are profiled in the report and the epidemiology of each of these indications is analysed and forecast to 2016. Leading products in each indication are identified, including those in the pipeline and their sales forecast to 2016. The leading players are profiled and their dermatology revenues forecast to 2016.

TechNavio’s analysts forecast the RFID market in the Healthcare industry to grow at a CAGR of 29 percent over the period of 2010–2014. One of the key factors contributing to this market growth is the reduced cost of RFID tags. The RFID market in the Healthcare industry has also been witnessing vendors entering into strategic alliances and partnerships.

Driven by a strong growth in the sales of temperature sensitive healthcare products, the demand for cold chain logistic services is currently experiencing explosive growth. IMARC Group, one of the world’s leading research and advisory firms, finds that the total size of the healthcare cold chain logistic services market is expected to expand from its current figures of US$ 6.1 billion to nearly US$ 9.5 billion by 2016.

The magnitude of research and development executed in neurostimulation innovation is high. Some of the prominent areas in neurostimulation where extensive clinical trails are executed include deep brain stimulation (DBS), spinal cord stimulation (SCS), and microstimulation.

This analysis examines the historical and forecast performance for GlaxoSmithKline in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

This analysis examines the historical and forecast performance for Genzyme in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Datamonitor’s Report “AstraZeneca: PharmaVitae Profile” is now available at ReportsnReports.com.

A wide variety of information technologies are now employed in support of clinical trials. Pharma companies are beginning to take a more holistic view and seek to integrate their management and oversight of the trial. This report examines how industry trends are shaping these technologies, and how they can be optimally applied to improve, quality, safety and efficiency in clinical trials.

The global cancer market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating this sector. This report presents leading products, developments, and market forecasts for each of these classes. Eighteen recently launched/late-stage pipeline products are discussed in detail.

This report covers the commercialization of stem cells (primarily derived from adult tissues) which are transplanted into patients to improve the function of diseased/damaged tissues/organs. Six indications are covered in detail. Sales forecasts are estimated in the US and five major European markets (5EU), which include France, Germany, Italy, Spain and the UK.